Tech Biotechnology: Majority of Developers Write Code and Use Machine Learning; Protein Engineering Is a Top Priority

Date:

Cradle, an innovative platform aiding scientists to create and program proteins, has recently conducted its first Biodeveloper survey in partnership with Bits in Bio, a global community devoted to developing software for scientists. The survey collected responses from more than 150 biodevelopers, offering a glimpse into the current landscape of the synthetic biology sector. The survey revealed that coding has become a critical skill for those working in biotech and many of these skills are self-taught. Moreover, Machine Learning has already been implemented by a majority of biodevelopers and is gaining more attention among scientists. Lastly, there is an obvious interest in protein engineering, with 71% of those surveyed already exploring or aiming to explore the subject.

Cradle is a business founded to simplify the designing and building of proteins. Therefore, the survey helped paint a picture of how biologists are utilizing technology in their work and what tools they are using. It is clear that coding and Machine Learning are playing an increasingly important role as the tools become more accessible. Furthermore, proteins are being seen as a potential solution to tackle many modern day issues, such as climate change and disease, with a notable interest from biodevelopers to explore this field.

Bits in Bio, through gathering feedback from the community, strives to advance communication between biodevelopers and help people learn best practices. With AI technologies evolving continuously, it is essential to navigate the intersection between software and science effectively. On the whole, the first BioDeveloper survey gave a lot of insight into the current trends of the synthetic biology sector.

See also  How Nvidia's Acquisition is Revolutionizing Machine Learning

From Cradle Bio B.V. is a company specialized in simplifying the designing and programming of proteins. Founded by Stef van Grieken, the company creates easy-to-use platforms that allow users to employ existing technologies to generate complex protein designs. Their ambition is to make custom protein design and programming accessible to all.

Nicholas Larus-Stone, the creator of Bits in Bio and CEO of Sphinx Bio, is dedicated to helping both scientists and developers make the most of the intersection between software and science. Through providing a global community devoted to the development of software for science, he hopes to facilitate greater communication amongst biodevelopers through feedback and results from the community.

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Samsung’s Foldable Phones: The Future of Smartphone Screens

Discover how Samsung's Galaxy Z Fold 6 is leading the way with innovative software & dual-screen design for the future of smartphones.

Unlocking Franchise Success: Leveraging Cognitive Biases in Sales

Unlock franchise success by leveraging cognitive biases in sales. Use psychology to craft compelling narratives and drive successful deals.

Wiz Walks Away from $23B Google Deal, Pursues IPO Instead

Wiz Walks away from $23B Google Deal in favor of pursuing IPO. Investors gear up for trading with updates on market performance and key developments.

Southern Punjab Secretariat Leads Pakistan in AI Adoption, Prominent Figures Attend Demo

Experience how South Punjab Secretariat leads Pakistan in AI adoption with a demo attended by prominent figures. Learn about their groundbreaking initiative.